Candesartan Cilexetil Tablet
Product Images NDC 46708-342

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil (NDC 46708-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30' Bottle Pack (Candesartan 16)

This is a description of Candesartan Cikexetl, USP 16mg tablets, manufactured by Alembic Pharmaceuticals Limited in India. The usual adult dosage is not mentioned, and one should see the package for it. The tablets should be stored at a temperature of 25°C (77°F), and excursions are permitted between 10-15°C to 30°C (59° to 86°F). The tablets are available in packages of 30 and require a prescription to be dispensed. The lot number mentioned is BXP.*

FDA Label Image

30' Bottle Pack (Candesartan 4)

Each tablet contains 4 mg of Candesartan Cilexeti, USP. It is an uncoated tablet and the usual adult dosage is not provided. The tablets should be stored between 15° to 30°C (59° to 86°F). It is manufactured by Alembic Pharmaceuticals Limited and the NDC code is 46708-341-30. The tablets come in a container of 30 tablets and the prescription is required. The text also provides information about the manufacturer's address, and the lot number but does not provide a useful description.*

FDA Label Image

30' Bottle Pack (Candesartan 8)

Each tablet contains 8mg of Candesartan Cikexetil. The usual adult dosage can be found in the package insert. The tablets should be stored between 15-30°C. The manufacturer is Alembic Pharmaceuticals Limited located in Gujarat, India. The tablets are sold in boxes containing 30 tablets and are only available with a prescription. The lot number is not available.*

FDA Label Image

Figure (Candesartan Fig)

This appears to be a tabular data showing patients' demographics and medical history variables such as age, sex, race, NYHA, LVEF, diabetes, hypertension, previous MI, atrial fibrillation, medications like ACE inhibitor, B-blocker, spironolactone, diuretic, digitalis, aspirin, and lipid-lowering. The table also presents a comparison between the groups of patients treated with Candesartan or Placebo. There is a column showing Hazard Ratio (95% CI) and years from 2004 to 2013. Therefore, this could be a medical study evaluating the effectiveness of Candesartan in comparison to Placebo on patients with the listed medical history variables.*

FDA Label Image

Structure (Candesartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.